EGCG exerts its anticancer effects through multiple mechanisms. It has been shown to inhibit cell proliferation, induce apoptosis (programmed cell death), and block angiogenesis (formation of new blood vessels) which is essential for tumor growth. Additionally, EGCG can modulate various signaling pathways such as the MAPK and PI3K/Akt pathways, which are often dysregulated in cancer.
